Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys (Q37121115)

18 August 2017

Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys (English)

1 reference

18 August 2017

Punam Sandhu

1 reference

18 August 2017

Xin Xu

1 reference

18 August 2017

Peter J Bondiskey

1 reference

18 August 2017

Suresh K Balani

1 reference

18 August 2017

Michael L Morris

1 reference

18 August 2017

Yui S Tang

1 reference

18 August 2017

Alisha R Miller

1 reference

18 August 2017

Paul G Pearson

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Antimicrobial Agents and Chemotherapy

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

1272-1280

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

18 August 2017

1 reference

Caspofungin: first approved agent in a new class of antifungals

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Caspofungin in the treatment of oropharyngeal candidiasis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Capofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Comparison of caspofungin and amphotericin B for invasive candidiasis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

Determination of an echinocandin, MK-0991, in mammalian plasma by radioimmunoassay

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=375331

3 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/15047529

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.48.4.1272-1280.2004

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

15047529

1 reference